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Background: A safe effective and affordable HIV vaccine is the most cost effective way to prevent HIV infection
worldwide. Current studies of HIV prevalence and incidence are needed to determine potentially suitable cohorts
for vaccine studies. The prevalence and incidence of HIV-1 infection among the police in Dar es Salaam in 1996
were 13.8% and 19.6/1000 PYAR respectively. This study aimed at determining the current prevalence and
incidence of HIV in a police cohort 10 years after a similar study was conducted.
Methods: Police officers in Dar es Salaam, Tanzania were prospectively enrolled into the study from 2005 and
followed-up in an incidence study three years later. HIV infection was determined by two sequential enzyme linked
immunosorbent assays (ELISAs) in the prevalence study and discordant results between two ELISAs were resolved
by a Western blot assay. Rapid HIV assays (SD Bioline and Determine) were used for the incidence study.
Results: A total of 1,240 police participated in the HIV prevalence study from August 2005 to November 2008. Of
these, 1101 joined the study from August 2005-September 2007 and an additional 139 were recruited between
October 2007 to November 2008 while conducting the incidence study. A total of 726 (70%) out of the 1043
eligible police participated in the incidence study.
The overall HIV-1 prevalence was 65/1240 (5.2%). Females had a non-statistically significant higher prevalence of HIV
infection compared to males 19/253, (7.5%) vs. 46/987 (4.7%) respectively (p = 0.07). The overall incidence of HIV-1
was 8.4 per 1000 PYAR (95% CI 4.68-14.03), and by gender was 8.8 and 6.9 per 1000 PYAR, among males and
females respectively, (p = 0.82).
Conclusions: The HIV prevalence and incidence among the studied police has declined over the past 10 years, and
therefore this cohort is better suited for phase I/II HIV vaccine studies than for efficacy trials.
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The overwhelming burden of HIV in sub-Saharan Africa
is of major concern and has claimed many lives in the
region [1].
Despite multiple preventive measures in place for the
control of HIV and AIDS, the disease still remains to be
of public health importance. According to the UNAIDS* Correspondence: patricia.munseri@ki.se
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reproduction in any medium, provided the orreport of 2011 there were 2.7 million new HIV infections
worldwide in 2010 [2]. While in Tanzania the HIV
prevalence was noted to be 6% [3].
Although the availability of highly active antiretroviral
therapy (HAART) has dramatically improved the quality
of life and life expectancy of people living with HIV and
AIDS, the ultimate control of this pandemic probably
depends upon the availability of a safe, effective and af-
fordable HIV vaccine.
Several vaccine candidates at different phases of trials,
including phase III trials have been tested in humans in
different continents and have been found to be safe andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cluded phase III study conducted in Thailand that re-
vealed a 31% efficacy [4].
Participation of sub-Saharan Africa in HIV vaccine tri-
als is crucial, since this is the region that bears the major
brunt of HIV infection and would be a potential region
to benefit most from a vaccine [5].
There is a need to prepare cohorts of volunteers for
HIV vaccine studies and moreover there is a need to as-
sess the suitability of these cohorts for such studies.
For phase I/IIa HIV vaccine studies the required co-
hort is supposed to be of low risk for HIV infection. For
efficacy studies where there is need to determine the ef-
ficacy of the vaccine candidate in question in the midst
of other non vaccine interventions the cohort to be stud-
ied is supposed to be at a relatively high risk for HIV in-
fection [6].
The police cohort in Dar es Salaam, Tanzania was
established in 1994 in preparation for phase I/II HIV vac-
cine trials in Dar-es Salaam. The initial HIV prevalence of
13.8% in this cohort was similar to the general population
prevalence for that year, while the incidence was noted to
be 19.9/1000 PYAR [7]. This is in the realm of incidence
where HIV vaccine efficacy trials are feasible.
A subgroup of these police officers, with low risk for
HIV infection, participated in a recently conducted
phase I/II HIV vaccine trial (HIVIS 03) to ascertain the
safety and immunogenicity of the candidate HIV-1
DNA-MVA vaccines [8].
During recruitment in the incidence study in 1994–
1996, study subjects were given HIV prevention educa-
tional sessions [7]. Furthermore a core group of more
than 300 police officers was established and maintained
with a focus to educate them more about HIV infection
and prevent transmission of HIV among members in the
police force.
HIV incidence in cohorts has been shown to decline
over time in many African countries including Tanzania
[1]. Our research group has maintained contacts with
the police force as a whole with regards to HIV educa-
tion and prevention as well as participation of the police,
among other cohorts, in phase I/II HIV vaccine trials
since 1994.
The aim of this study was therefore to determine the
current HIV prevalence and incidence among the police
in Dar es Salaam. This study is conducted 10 years fol-
lowing the initial HIV prevalence and incidence study so
as to determine if the police force is still a suitable co-
hort for HIV vaccine efficacy studies.
Methods
Setting
The study was conducted at all the 32 police stations





Recruitment began in August 2005 and follow up was
complete in November 2008.
Study population
Were police men and women aged 18 years or above
from Dar es Salaam Tanzania. They were prospectively
recruited into the study following educational sessions
on HIV and AIDS that were done in their respective sta-
tions. Physicians conducted the educational sessions
with the help of collaborators from the Police force that
included Doctors and Nurses from the police health unit
on a weekly basis. After each educational session, the
police were invited to participate in the study, prior to
participation in the study an informed consent was
obtained from each of the police.
Trained nurse counselors performed pre and post-test
HIV counseling to all study subjects. The nurse coun-
selors also filled in a standardized questionnaire that
included socio-demographic data, social behavioral ques-
tions on HIV risk and questions on HIV testing. After
the interview sessions the study participants were re-
quested to donate blood for HIV testing.
Following HIV testing in the Microbiology and Im-
munology laboratory at the Muhimbili University of
Health and Allied Sciences, the HIV results were commu-
nicated to the respective study subject at their respective
stations a week later whereby post-test counseling was
performed by a nurse counselor.
Follow up
For the incidence study the study staff visited the sta-
tions from October 2007 to November 2008 and re-
quested all those who participated in the prevalence
study in 2005–2008 to re-test for HIV. Only participants
who were not HIV infected in the prevalence study were
tested for HIV in the incidence study.
Blood sample collection
Two milliliters of venous blood was collected for HIV
testing at the Department of Microbiology and Im-
munology, Muhimbili University of Health and Allied
Sciences (MUHAS).
HIV testing
For the HIV prevalence study: HIV serostatus was de-
termined using the Murex antigen/antibody combina-
tion (Abbott, UK) enzyme linked immunosorbent assays
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Enzygnost anti-HIV-1/HIV-2 plus (Behring, Marbug,
Germany) assay as previously used [9]. Discordant re-
sults between two ELISAs were confirmed using Inno-
Lia immunoblot assay (Innogenetics, Belgium).
For the HIV Incidence study: HIV serostatus was de-
termined using the National rapid HIV testing algorithm
where initial testing was performed using SD Bioline
(Standard Diagnostic Inc, Korea) followed by confirma-
tion of reactive samples on Determine (Inverness Med-
ical, Japan) as used previously [10]. Sera reactive on both
tests were considered as positive. Uni-Gold assay (Trinity,
UK) was used as a tiebreaker. The change in testing meth-
odology was determined by the fact that the study partici-
pants did not want to wait for a week for their HIV test
results. Furthermore it was noted that there were several
voluntary and counseling testing sites that offered HIV
testing and results on the same day.
Social characteristics
Information on social behavioral characteristics was col-
lected on a subgroup of individuals who participated in
the prevalence study in 2005. This subgroup only in-
cluded the police who were recruited consecutively in
the study for the first six months. Thereafter this infor-
mation was not collected as it was noted that this con-
sumed a lot of time as the police needed to attend to
their duties.
Ethical clearance
The study received ethical clearance from the Muhimbili
University of Health and Allied Sciences ethics commit-
tee. Written informed consent was obtained from each
study participant prior to the inclusion in the study. In-
formed consent was obtained from each police who par-
ticipated and there was no coercion from the higher
authorities in the Police Force.
Treatment
All study subjects who were found to be HIV-infected
were referred to the Muhimbili National Hospital, HIV
care and treatment clinic and were offered standard of
care according to the Tanzania National Guidelines for
Care and Treatment of HIV-infected patients.
Data analysis
Data were analyzed using SPSS version 18 software
(SPSS, Chicago, IL, US). 95% Confidence intervals were
computed using Open Epi version 2 that is available
on line in the following link (http://www.openepi.com/
OE2.3/PersonTime1/PersonTime1.htm) the test was used
to compare proportions and incidence rates between
the sexes. Two by two tables were used to compare
social demographic variables between males and females.Comparisons were made for the social demographic vari-
ables by gender as stratified by HIV status. Comparison of
proportions was made using the Chi square test. HIV inci-
dence was estimated from the time the first HIV test was
negative to the time the test was positive. Since partici-
pants had different follow up times. The incidence rates
were calculated as the number of new HIV infections
divided by the person time years of observation for
each study participant. Relative risk was used to com-
pare the HIV incidence by gender and statistical sig-
nificance was judged using a 95% confidence interval.




A total of 1,367 police from the 32 stations in Dar-es
Salaam were provided with education on HIV by the study
team. Of these 1,244 (91%) consented for a blood withdra-
wal for HIV testing: 991/1244 (80%) were male.
There was no significant difference between females
and males with respect to agreeing to a blood withdra-
wal and subsequent HIV testing 253/282 (90%) vs 991/
1085 (91%), respectively (p = 0.64). When it came to ac-
tual testing 1240 (99.7%) were tested for HIV, with only
4 (0.3%) participants who had consented not showing up
for the blood test.
The demographic characteristics of the study popula-
tion are shown in Table 1. Only a subset of the study
population were asked questions on social risk behaviour
for practical reasons, due to a tight schedule at the wor-
king place that left minimal time for the study par-
ticipants to fill in the questionnaire. The sub group
comprised of 435 police, 88 females and 347 males from
the police who were recruited into the study during the
first six months of the study.
The females who participated in the study were
much younger compared to males with a median age
of 33 years compared to 37 years respectively p < 0.001.
Likewise a significantly higher proportion of females
(45.5%) were not married compared to males (25.4%)
p<0.001.
Participant recruitment
Recruitment of study participants and the flow is shown
in Figure 1. Of the 1,240 who tested for HIV 1,101
(89%%) were seen in the first round from August 2005 to
August, 2007. The remaining 139 were tested for HIV
prevalence during the second round while conducting the
incidence study that took place between October 2007
and November 2008.
A total of 726 out of the 1,043 (70%) eligible police
were seen for a second time for the incidence study bet-
ween October 2007- November 2008. The remaining
Table 1 Socio-demographic and behavioral characteristics
of the study participants who participated in the first
round of the prevalence study
Characteristic Male Female P value
Median age (range) 37 (18–61) 33 (18–57) <0.001
Mean Age (SD) 36 (±9.2) 34 (±9.5)
Marital Status (n=435)
Never married 88 (25.4%) 40 (45.5%) <0.001
Married 259 (74.6%) 48 (55.5%)
Level of education (n=433)
Primary 138 (40.0%) 38 (43.2%)
Secondary 189 (54.8%) 47 (53.4%) 0.751
College/university 18 (5.2%) 3 (3.4%)
Condom use last sexual
encounter (n=307)
Yes 28 (10.9%) 9 (17.6%) 0.163
No 228 (89.1%) 42 (82.4%)
Regular sexual partner
Wife/Husband (n=304)
Yes 237 (93.3%) 35 (70.0%) <0.001
No 17 (6.7%) 15 (30.0%)
Regular sexual partner
someone else (n=226)
Yes 105 (59.7%) 29 (58.0%)
No 71 (40.3%) 21 (42.0%) 0.871
Condom use during
extramarital sex (n = 21)
Yes 12 (70.6%) 4 (100%) 0.50
No 5 (29.4%) 0 (0%)
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(21%) were female, and 252 (79%) were male. We were
able to obtain reasons for not re-testing in 213/317
(67%). The reasons included: being transferred perman-
ently 63 (30%); being away on special assignment during
the study period 53 (25%), retired in 21 (10%), being on
vacation 19 (9%); being on study leave 17 (8%), with-
drawn consent 16 (7%), terminated from the force 12
(6%); death 5 (2%), hospitalized 3 (1%), resigned 2 (1%),
and travelled 2 (1%).
HIV prevalence
The overall prevalence of HIV-1 infection was 65/1240
(5.2%) with a statistically non-significant higher preva-
lence among females 19/253 (7.5%) compared to males
46/987 (4.7%) p = 0.07. The HIV prevalence during the
first round was 58/1101 (5.3%) and in the second round
was 6/139 (4.3%).
Socio-demographic characteristics related to HIV se-
rostatus are shown in Table 2. HIV infection was com-
mon among the older police officers for both males andfemales, however this difference by gender was not sta-
tistically significant. Further, men who refused to test
were younger compared to the men who tested for HIV.
The HIV-1 prevalence was higher among married com-
pared to never married police, (7.8% vs 2.3%, p = 0.03).
HIV infection seemed to be more prevalent among those
with lower levels of education compared to those with
higher level of education; 9.1% vs 4.7% p = 0.06.
HIV incidence
Of the 1,043 police who were HIV-negative at recruitment
during the prevalence study in 2005, 726 (70%) were
followed up until 2008 and generated a total of 1,538 per-
son time years of observation (PYAR). Among the 726 po-
lice who were followed up 13 police seroconverted. The
overall crude HIV-1 incidence was thus 13/726 (1.79%).
The HIV incidence by gender and age are shown in
Table 3. The crude HIV-1 incidence by gender was 1.4%
(2/143) for females and 1.9% (11/583) for males, p = 0.98.
The incidence rate of HIV-1 was 13/1538 (0.85%) or 8.5
per 1000 PYAR (95% CI 4.68-14.03). By gender this was
0.88% (8.8/1000 PYAR) among males, and 0.69% (6.9/1000
PYAR) for females with a relative risk of 0.8 (95% CI
0.31-8.39), p = 0.82 for females compared to males.
The age group with the highest HIV incidence for
males and females was 25–29 years with incidence rates
of 18.7 and 43.5 per 1000 PYAR for males and females
respectively.
Discussion
This study has found out that the overall HIV preva-
lence and incidence among the police officers in Dar es
Salaam has decreased to 5.2% and 8.5 per 1000 PYAR
respectively over the past decade as compared to the
previous study [7]. In 1994/96, the prevalence and inci-
dence of HIV among the police were 13.8% and 19.9 per
1000 PYAR respectively [7]. The prevalence of HIV
among the police is comparable to the national figures
in the general population of Tanzania of 6% [3].
We observed that HIV was more prevalent among the
married compared to the never married and HIV was
also more prevalent among those with lower levels of
education compared to those with higher levels of edu-
cation. This finding is in-keeping with a previous study
in Tanzania [11].
We also found that the HIV incidence was high among
the age group of 25–29years for both males and females.
When comparing this to the previous study that was
conducted in 1994/96 the HIV incidence for females in
the same age group has doubled from 20.4 per 1000 to
43 per 1000 in the present study. For males no such dif-
ference was observed, i.e. 17.1 per 1000 to 19 per 1000
in the present study. However we noted that the higher




































Figure 1 Consort diagram.
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pared to 30–34 years in the 1994/96 study [7].
The reduction in the HIV prevalence and incidence
among the police could be attributed to the continuous
HIV educational sessions that have been ongoing on
average at weekly intervals in the police force. The study
team had recruited the police for a phase 1/II HIV vac-
cine trial and prior to recruitment in the study, conti-
nuous HIV prevention educational sessions have been
conducted in the various stations in Dar es Salaam. Fur-
thermore there has been massive campaigns country-
wide against HIV and AIDS, which might have also
resulted into the decrease in prevalence country wide as
well as in the police force.
It was also learnt that at the beginning of 2005 there
was a policy for mandatory HIV screening of new police
recruits and only those found to be HIV-uninfected wererecruited into the police force. We speculate that this
factor might have also contributed to the low prevalence
noted in the current study. Perhaps the HIV infected
screened out recruits from the police force could have
increased the prevalence in this study. Furthermore the
low incidence observed in our study could also be attri-
buted to the fact that the current study might have se-
lected for police who might have been at low risk, as
almost 30% of the police who participated in the preva-
lence study did not re-test in the incidence study.
Generally there has been a reported decline in HIV
prevalence and incidence in Tanzania in the general po-
pulation that is comparable to our study [2].
On comparing these study findings to the previous in-
cidence study conducted among the police in 1996 [7]
whereby 2,733 police we recruited over a 3-year period,
we only recruited 1240 police over a similar interval of
Table 2 HIV Prevalence by socio- demographic and behavioral characteristics
All Males Females Total
Median age (years range)
HIV-infected 39 (22–51) 39 (26–51) 38 (22–49)
HIV-uninfected 36 (18–61) 37 (19–61) 34 (18–56) 0.07




HIV-infected 3 (2.3%) 2 (2.3%) 1 (2.5%)
HIV-uninfected 125 (97.7%) 86 (97.7%) 39 (97.5)
0.03*
Married
HIV-infected 24 (7.8%) 20 (7.7%) 4 (8.3%)




HIV-infected 16 (9.1%) 13 (9.4%) 3 (7.9%)
HIV-uninfected 160 (90.9%) 125 (90.6%) 35 (92.1%)
Secondary 0.06**
HIV-infected 11 (4.7%) 9 (4.8%) 2 (4.1%)
HIV-uninfected 225 (95.3%) 180 (95.2%) 45 (95.7%)
College/university
HIV-infected 0 0 0
HIV-uninfected 21 18 3
Condom use last sexual encounter
n=307
Yes
HIV-infected 3 (8.1%) 1 (3.6%) 2 (22.2%)
HIV-uninfected 34 (91.9%) 27 (96.4) 7 (77.8%)
0.76***
No
HIV-infected 21 (7.8%) 18 (7.9%) 3 (7.1%)
HIV-uninfected 249 (92.2%) 210 (92.1%) 39 (92.9%)
Regular sexual partner Wife/Husband
n=304
Yes
HIV-infected 22 (8.1%) 19 (98.0%) 3 (8.6%)
HIV-uninfected 250 (91.9%) 218 (92.0%) 32 (91.4%)
0.93****
No
HIV-infected 2 (6.3%) 1 (5.9%) 1 (6.7%)
HIV-uninfected 30 (93.7%) 16 (94.1%) 14 (93.3%)
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Table 2 HIV Prevalence by socio- demographic and behavioral characteristics (Continued)
Regular sexual partner someone else
n=226
Yes
HIV-infected 6 (4.5%) 6 (5.7%) 0
HIV-uninfected 128 (95.5%) 99 (94.3%) 29
0.95
No
HIV-infected 5 (5.4%) 3 (4.2%) 2 (9.5%)
HIV-uninfected 87 (94.6%) 68 (95.8%) 19 (90.5%)
* p values comparison of HIV –infection among the married to the never married.
** p values comparison of HIV-infection in primary vs secondary education.
*** p values comparison of HIV-infection among the condom users and non condom users.
**** p values comparison of HIV-infection with respect for regular sexual partners and irregular sexual partners.
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could have been attributed to the availability of HIV
testing facilities in the city including a testing center at
the police health center.
Of recent there has been an increase in voluntary
counseling and testing centers in Tanzania. We noted
that some of the police had tested for HIV in less than
3 months at these centers and knew their statuses. Some
of the police when traced could not be followed up
as they were assigned special duties outside the city
or abroad.
During the incidence study we changed to rapid tes-
ting for HIV whereby we tested and offered results on
site on the same setting. In addition we also offered
other tests such as hemoglobin, glucose and urine exam-
ination so as to motivate the police to test. However we
might have selected for police who had tested them-
selves prior and had known that they were uninfected
and therefore participated in this study resulting to the
underestimation of the prevalence and incidence.
For HIV efficacy trials there is a need to recruit a
high-risk cohort so as to study the effect of the vaccine
in the midst of other existing preventive measures and
to reach to a primary endpoint in a relatively short
period of time. The incidence of 8.5 per 1000 PYAR ob-
served in the current study clearly indicates that the








18–24 98 195 1 5.1
25–29 105 214 4 18.7
30–34 51 114 1 8.8
35+ 329 727 5 6.9
Total 583 1250 11 8.8
R.R Relative risk.
PYAR Person years at risk.might not be a suitable cohort for HIV vaccine efficacy
studies though a decade ago the cohort appeared to be
suitable for efficacy trials. However, there might be sev-
eral factors that motivated individuals to participate in
vaccine trials, one of the factors could be self-perception
of being at high risk. In the recently concluded phase I/II
HIV vaccine study (HIVIS03 study) that was conducted
among the police in Dar es Salaam over a two year period
2/60 recruited volunteers acquired HIV infection during
the study this amounts to an incidence of 16.7 per 1000
PYAR [8]. These police who participated in the vaccine
trial are from the same stations where the incidence study
was conducted and yet the incidence noted in our study
was half of that noted in the vaccine study. This might
therefore indicate that the police who came to test in the
incidence study might have perceived themselves to be at
low risk and therefore our study selected for individuals at
low risk.
Conclusions
There has been an overall decline in the HIV prevalence
and incidence in the police cohort. Therefore the police in
Dar es Salaam are a suitable cohort for phase I/II HIV vac-
cine studies but might not be a suitable cohort for efficacy
studies. Hence efforts are continued to explore other pos-
sible cohorts such as young females at high risk for HIV




HIV Cases Incidence R.R
36 68 0 0
26 46 2 43.5 2.3
18 35 0 0
63 139 0 0
143 288 2 6.9 0.8
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